Serotonin research: Crossing scales and boundaries.

Neuropharmacology

Centre National de La Recherche Scientifique, UMR CNRS 5287, Bordeaux Cedex, France. Electronic address:

Published: December 2020

Nearly 100 years after the discovery of serotonin, its role remains elusive. Modulation of serotonin transmission is considered in numerous central nervous system (CNS) diseases including depression, anxiety, schizophrenia, obsessive-compulsive disorders, addiction, Parkinson's disease, and Alzheimer's disease. The therapeutic strategies based on serotonin systems have evolved thanks to better identification of the involvement of serotonin in various diseases, the better use of animal models, a better understanding of the molecular environment of serotonin receptors, and ultimately the better understanding of the interaction of serotonin neurotransmission with other biological systems. Some 5-HT receptors are still the object of numerous investigations including 5-HT, 5-HT, and 5-HT receptor subtypes. It is noteworthy that the direction of research is moving towards a simultaneous action at multiple targets either through different 5-HT targets or the consideration of both 5-HT and other targets to achieve better therapeutic responses.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neuropharm.2020.108340DOI Listing

Publication Analysis

Top Keywords

better understanding
8
5-ht 5-ht
8
5-ht targets
8
serotonin
7
5-ht
6
better
5
serotonin crossing
4
crossing scales
4
scales boundaries
4
boundaries 100
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!